Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir for Non-Severe COVID-19 Pneumonia
jRCT2080225142Phase 3Completed
- Sponsor
- FUJIFILM Toyama Chemical
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) and pneumonia comparing Favipiravir with Placebo (2 arms). Started Mar 2020; status: completed.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonia
Beyond the preview
Go deeper on jRCT2080225142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225142.